Cano, A.; Muñoz-Morales, Á.; Sánchez-López, E.; Ettcheto, M.; Souto, E.B.; Camins, A.; Boada, M.; Ruíz, A.
Exosomes-Based Nanomedicine for Neurodegenerative Diseases: Current Insights and Future Challenges. Pharmaceutics 2023, 15, 298.
https://doi.org/10.3390/pharmaceutics15010298
AMA Style
Cano A, Muñoz-Morales Á, Sánchez-López E, Ettcheto M, Souto EB, Camins A, Boada M, Ruíz A.
Exosomes-Based Nanomedicine for Neurodegenerative Diseases: Current Insights and Future Challenges. Pharmaceutics. 2023; 15(1):298.
https://doi.org/10.3390/pharmaceutics15010298
Chicago/Turabian Style
Cano, Amanda, Álvaro Muñoz-Morales, Elena Sánchez-López, Miren Ettcheto, Eliana B. Souto, Antonio Camins, Mercè Boada, and Agustín Ruíz.
2023. "Exosomes-Based Nanomedicine for Neurodegenerative Diseases: Current Insights and Future Challenges" Pharmaceutics 15, no. 1: 298.
https://doi.org/10.3390/pharmaceutics15010298
APA Style
Cano, A., Muñoz-Morales, Á., Sánchez-López, E., Ettcheto, M., Souto, E. B., Camins, A., Boada, M., & Ruíz, A.
(2023). Exosomes-Based Nanomedicine for Neurodegenerative Diseases: Current Insights and Future Challenges. Pharmaceutics, 15(1), 298.
https://doi.org/10.3390/pharmaceutics15010298